Show simple item record

dc.contributor.authorRash, Wendy
dc.date.accessioned2021-08-19T14:52:04Z
dc.date.available2021-08-19T14:52:04Z
dc.date.issued2021-08
dc.identifier.urihttps://lair.lr.edu/handle/20.500.12862/38
dc.description.abstractPatients with nephrostomy/nephroureteral stents undergo exchange procedures every six to eight weeks to maintain patency. This procedure is commonly performed with moderate sedation using opioid medications. These medications are not without risks relating to maintenance of airway and rate of breathing. A quality improvement study was conducted to evaluate the effectiveness of adding ketorolac to a reduced amount of opioid administration during this procedure to examine pain scores. Pain scores were measured by the Visual Analogue Scale during the pre procedure, during procedure and post procedure periods. Ketorolac has shown to be effective in other areas of pain management but there was a gap in research related to this procedure. Six of the ten patients required half of the previous total of opioids. Four of the ten patients received the full dose of opioids. There were no significant differences between these groups in pre procedure pain score or the post procedure pain score. The patients receiving half the dose of opioids were able to achieve similar pain control compared to those patients receiving the full dose.en_US
dc.language.isoen_USen_US
dc.subjectResearch Subject Categories::INTERDISCIPLINARY RESEARCH AREAS::Caring sciences::Nursingen_US
dc.subjectOpioiden_US
dc.subjectPainen_US
dc.subjectNephrostomyen_US
dc.subjectNephroureteralen_US
dc.subjectSedationen_US
dc.subjectKetorolacen_US
dc.titleUtilization of Ketorolac for Pain Control During Nephrostomy and Nephroureteral Stent Exchange: A Quality Improvement Studyen_US
dc.typeThesisen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record